Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Frizzled 3 and Frizzled 6 together control the orientation of mouse hair follicles.

miRNA-24 affects goat coat color by controlling proteins involved in pigment production.

LRIG1 is linked to better survival in Merkel cell carcinoma.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Overexpression of LRIG3 in skin causes hair loss.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

MEX3A is crucial for maintaining intestinal stem cells in mice.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

The cerium-polypeptide hydrogel effectively heals drug-resistant bacterial wounds by fighting bacteria, reducing inflammation, and promoting tissue repair.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.